Feeds › Lobbying
Lobbying
Who pays Washington lobbyists, how much, and on which issues.
About this data
- What it is
- Companies and trade groups that pay for lobbying must report it to Congress every quarter: who they hired, how much they spent, and which issues were lobbied.
- Who files it
- The lobbying firm, or the company itself when it uses its own staff, under the Lobbying Disclosure Act.
- How current
- Quarterly reports are due 20 days after each quarter ends, so they arrive in waves. We collect them daily.
- Worth knowing
- Amounts are rounded by the filer and cover the whole quarter. We match clients to listed companies automatically, so a few may be missed or misattributed.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Lobbying filings per day, last 30 days
All filings Of listed companies
Quarterly reports are due 20 days after each quarter ends, so filings come in waves.
Latest lobbying filings
Showing: ticker NVO
| Posted | Client | Lobbying firm | Report | AmountWhen a company hires a lobbying firm, the firm reports the income it received. When the company lobbies with its own staff, it reports its expenses instead. | Issues | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2026 | NVO Novo Nordisk A/S | Williams and Jensen, PLLC | 2026 third quarter | $60.0K | HCR, BUD, MMM, TAX | LDA ↗ |
| Oct 20, 2026 | NVO Novo Nordisk A/S | Tarplin, Downs & Young, LLC | 2026 third quarter | $60.0K | HCR, MMM, BUD | LDA ↗ |
| Oct 20, 2026 | NVO Novo Nordisk A/S | Todd Strategy Group | 2026 third quarter | $60.0K | HCR, PHA | LDA ↗ |
| Oct 20, 2026 | NVO Novo Nordisk A/S | Novo Nordisk Inc. | 2026 third quarter | $2.0M | MMM, CPT, TAX, TAR | LDA ↗ |
| Oct 20, 2026 | NVO Novo Nordisk A/S | NVG, LLC | 2026 third quarter | $80.0K | HCR, MMM | LDA ↗ |
| Oct 19, 2026 | NVO Novo Nordisk A/S | The Nickles Group, LLC | 2026 third quarter | $80.0K | HCR, MMM, TAX, TRD | LDA ↗ |
| Oct 19, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 third quarter | $80.0K | CSP, PHA, HCR, MMM | LDA ↗ |
| Oct 19, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 third quarter | — | LDA ↗ | |
| Oct 18, 2026 | NVO Novo Nordisk A/S | Ballard Partners | 2026 third quarter | $120.0K | PHA | LDA ↗ |
| Oct 17, 2026 | NVO Novo Nordisk A/S | Holland & Knight LLP | 2026 third quarter | $60.0K | BUD, HCR | LDA ↗ |
| Oct 16, 2026 | NVO Novo Nordisk A/S | S-3 Group | 2026 third quarter | $60.0K | HCR, MMM, TRD | LDA ↗ |
| Oct 15, 2026 | NVO Novo Nordisk A/S | Checkmate Government Relations | 2026 third quarter | $90.0K | HCR | LDA ↗ |
| Jul 21, 2026 | NVO Novo Nordisk A/S | Todd Strategy Group | 2026 second quarter | $60.0K | HCR | LDA ↗ |
| Jul 20, 2026 | NVO Novo Nordisk A/S | NVG, LLC | 2026 second quarter | $80.0K | MMM, HCR | LDA ↗ |
| Jul 20, 2026 | NVO Novo Nordisk A/S | Williams and Jensen, PLLC | 2026 second quarter | $60.0K | HCR, BUD, MMM, TAX | LDA ↗ |
| Jul 20, 2026 | NVO Novo Nordisk A/S | Tarplin, Downs & Young, LLC | 2026 second quarter | $60.0K | HCR, MMM, BUD | LDA ↗ |
| Jul 20, 2026 | NVO Novo Nordisk A/S | Novo Nordisk Inc. | 2026 second quarter | $1.3M | HCR, BUD, MMM, CPT | LDA ↗ |
| Jul 20, 2026 | NVO Novo Nordisk A/S | The Nickles Group, LLC | 2026 second quarter | $80.0K | HCR, MMM, TAX, TRD | LDA ↗ |
| Jul 19, 2026 | NVO Novo Nordisk A/S | Holland & Knight LLP | 2026 second quarter | $60.0K | BUD, HCR | LDA ↗ |
| Jul 17, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 second quarter | $70.0K | HCR, MMM, CSP, PHA | LDA ↗ |
| Jul 17, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 second quarter | — | LDA ↗ | |
| Jul 17, 2026 | NVO Novo Nordisk A/S | S-3 Group | 2026 second quarter | $20.0K | HCR, MMM, TRD | LDA ↗ |
| Jul 16, 2026 | NVO Novo Nordisk A/S | Ballard Partners | 2026 second quarter | $120.0K | PHA | LDA ↗ |
| Jul 15, 2026 | NVO Novo Nordisk A/S | Checkmate Government Relations | 2026 second quarter | $90.0K | HCR | LDA ↗ |
| Apr 22, 2026 | NVO Novo Nordisk A/S | Public Strategies Washington, Inc. | 2026 first quarter | $10.0K | LDA ↗ | |
| Apr 20, 2026 | NVO Novo Nordisk A/S | Avoq, LLC | 2026 first quarter | $20.0K | HCR | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | NVG, LLC | 2026 first quarter | $80.0K | MMM, HCR | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | Tarplin, Downs & Young, LLC | 2026 first quarter | $60.0K | HCR, MMM, BUD | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | Todd Strategy Group | 2026 first quarter | $60.0K | HCR | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | Novo Nordisk Inc. | 2026 first quarter | $1.3M | HCR, BUD, MMM, CPT | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | Williams and Jensen, PLLC | 2026 first quarter | $60.0K | HCR, BUD, MMM, TAX | LDA ↗ |
| Apr 20, 2026 | NVO Novo Nordisk A/S | The Nickles Group, LLC | 2026 first quarter | $80.0K | HCR, MMM, TAX, TRD | LDA ↗ |
| Apr 17, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 first quarter | — | LDA ↗ | |
| Apr 17, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2026 first quarter | $80.0K | PHA, HCR, MMM, CSP | LDA ↗ |
| Apr 17, 2026 | NVO Novo Nordisk A/S | S-3 Group | 2026 first quarter | $20.0K | HCR, MMM, TRD | LDA ↗ |
| Apr 16, 2026 | NVO Novo Nordisk A/S | Ballard Partners | 2026 first quarter | $120.0K | PHA | LDA ↗ |
| Apr 15, 2026 | NVO Novo Nordisk A/S | Checkmate Government Relations | 2026 first quarter | $90.0K | HCR | LDA ↗ |
| Apr 10, 2026 | NVO Novo Nordisk A/S | Holland & Knight LLP | 2026 first quarter | $60.0K | BUD, HCR | LDA ↗ |
| Apr 7, 2026 | NVO Novo Nordisk A/S | S-3 Group | 2026 first quarter | — | HCR, MMM, TRD | LDA ↗ |
| Jan 21, 2026 | NVO Novo Nordisk A/S | Todd Strategy Group | 2025 fourth quarter | $60.0K | HCR | LDA ↗ |
| Jan 21, 2026 | NVO Novo Nordisk A/S | NVG, LLC | 2025 fourth quarter | $80.0K | MMM, HCR | LDA ↗ |
| Jan 21, 2026 | NVO Novo Nordisk A/S | Avoq, LLC | 2025 fourth quarter | $60.0K | HCR | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | Tarplin, Downs & Young, LLC | 2025 fourth quarter | $60.0K | HCR, MMM, BUD | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | Williams and Jensen, PLLC | 2025 fourth quarter | $60.0K | HCR, BUD, MMM, TAX | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | Public Strategies Washington, Inc. | 2025 fourth quarter | $30.0K | MMM | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | The Nickles Group, LLC | 2025 fourth quarter | $80.0K | HCR, MMM, TAX, TRD | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | Novo Nordisk Inc. | 2025 fourth quarter | $2.1M | HCR, BUD, MMM, CPT | LDA ↗ |
| Jan 20, 2026 | NVO Novo Nordisk A/S | Checkmate Government Relations | 2025 fourth quarter | $90.0K | HCR | LDA ↗ |
| Jan 15, 2026 | NVO Novo Nordisk A/S | Ballard Partners | 2025 fourth quarter | $120.0K | LDA ↗ | |
| Jan 14, 2026 | NVO Novo Nordisk A/S | Arnold & Porter Kaye Scholer LLP | 2025 fourth quarter | $70.0K | PHA, HCR, MMM, CSP | LDA ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 6:30 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances